BG Hexal 1 A Pharma GbR (bestehend aus Hexal AG, 1 A Pharma GmbH)

Germany – Pharmaceutical Contracts for Generic Medicines

This contract involves establishing active ingredient-based discount agreements in accordance with § 130a Abs. 8 SGB V for specific pharmaceuticals. The agreements will be in effect for a maximum period of 24 months, starting no earlier than April 1, 2026, and ending uniformly on March 31, 2028. Sup